Cyclosporin monitoring in australasia: Survey of laboratory practices in 2000

Therapeutic Drug Monitoring

Volumn 24, Issue 4, 2002, Pages 471-478

  Morris, Raymond G ^a   Lam, Ada K ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Cyclosporin; Therapeutic drug monitoring; Transplantation

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A;

AREA UNDER THE CURVE; ASIA; AUSTRALIA AND NEW ZEALAND; CLINICAL PRACTICE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG MONITORING; HUMAN; KIDNEY TRANSPLANTATION; LABORATORY; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW;

AUSTRALIA; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LABORATORIES; NEW ZEALAND; ORGAN TRANSPLANTATION; PRACTICE GUIDELINES; QUALITY CONTROL; QUESTIONNAIRES;

EID: 0036340336     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200208000-00002     Document Type: Review

References (16)

1. Australian cyclosporin therapeutic monitoring survey - 1993
2. Survey of cyclosporin therapeutic ranges, assay methodology and use of 'sparing agents' in Australasian transplant centres
3. Cyclosporin-A monitoring in Australia: Consensus recommendations
4. Lake Louise consensus meeting on cyclosporin monitoring in organ transplantation: Report of the consensus panel
5. Canadian consensus meeting on cyclosporine monitoring: Report of the consensus panel
6. Critical issues in cyclosporin monitoring: Report of the task force on cyclosporin monitoring
7. Consensus Document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine
8. Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoring
9. Performance and specificity of monoclonal immunoassays for cyclosporin monitoring: How specific is specific?
10. Improved clinical outcomes for liver transplant recipients using cyclosporin blood level monitoring based on two-hour post-dose levels
11. Neoral monitoring by simplified sparse sampling area under the concentration-time curve
12. Stimulated response of peripheral lymphocytes may distinguish cyclosporin effect in renal transplant recipients receiving a cyclosporin + rapamycin regimen
13. Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients
14. Absorption profiling of cyclosporine therapy de novo kidney transplantation: A prospective, randomised study comparing sparse sampling to trough monitoring
15. Target concentration strategy for cyclosporin monitoring
16. Methods for clinical monitoring of cyclosporin in transplant patients